See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.
The Shared Resources of the Abramson Cancer Center (ACC), also called Core Facilities, provide investigators with easy access to state-of-the-art research technology, equipment, technical support, data, and biostatistics services that would otherwise be too difficult or expensive for individual investigators or Programs to develop and maintain. The availability of the ACC Shared Resources significantly facilitates the ease with which cancer-related research can be conducted at Penn.
The ACC BioRepository enables the collection of tumor and normal tissue samples.
The Biostatistics and Bioinformatics Core provides consultation and assistance for basic, translational, clinical, and epidemiologic research in cancer.
The Comparative Pathology Core provides investigators with skillful interpretation of lesions in animal models.
The Flow Cytometry and Cell Sorting Facility provides sophisticated flow cytometry, cell sorting services, and scientific expertise for research projects.
The Genomic Analysis Core merges the DNA Sequencing and the Genomics Facility to provide an array of services for DNA sequencing and molecular profiling.
The Human Immunology Core supports clinical trials and immunology research with state-of-the-art immune assays, cellular products, and immunological expertise.
The Metabolomics Core provides state-of-the-art targeted and untargeted metabolomics and lipidomics services.
The Small Animal Imaging Facility is a Shared Resource providing advanced instrumentation and technical support to apply a broad range of imaging modalities to small animal models.
The Stem Cell and Xenograft Core integrates a viable tissue bank of normal human hematopoietic cells and hematopoietic malignancies with a full range of xenograft services.
The Transgenic and Chimeric Mouse Facility provides expertise in a range of transgenic technologies and regularly introduces new services.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.